These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 27631819)
21. Mobilization of γδ T Cells and IL-10 Production at the Acute Phase of Hepatitis E Virus Infection in Cytomegalovirus Carriers. Barragué H; Fontaine J; Abravanel F; Mauré E; Péron JM; Alric L; Dubois M; Izopet J; Champagne E J Immunol; 2021 Mar; 206(5):1027-1038. PubMed ID: 33483348 [TBL] [Abstract][Full Text] [Related]
22. Gene expression profiles of T cells from hepatitis E virus infected patients in acute and resolving phase. TrehanPati N; Sukriti S; Geffers R; Hissar S; Riese P; Toepfer T; Guzman CA; Sarin SK J Clin Immunol; 2011 Jun; 31(3):498-508. PubMed ID: 21287396 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic performance of selected commercial HEV IgM and IgG ELISAs for immunocompromised and immunocompetent patients. Pas SD; Streefkerk RH; Pronk M; de Man RA; Beersma MF; Osterhaus AD; van der Eijk AA J Clin Virol; 2013 Dec; 58(4):629-34. PubMed ID: 24210958 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of an antigen assay for diagnosing acute and chronic hepatitis E genotype 4 infection. Zhang H; Rao H; Wang Y; Wang J; Kong X; Ji Y; Zhu L; Liu Y; Fang J; Yang M; Luo B; Wang Z; Shi Y; Wang Y; Wang H; Zhao J; Wei L J Gastroenterol Hepatol; 2019 Feb; 34(2):458-465. PubMed ID: 30069920 [TBL] [Abstract][Full Text] [Related]
25. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques. Bremer W; Blasczyk H; Yin X; Salinas E; Grakoui A; Feng Z; Walker C J Hepatol; 2021 Sep; 75(3):557-564. PubMed ID: 33961939 [TBL] [Abstract][Full Text] [Related]
26. Immune dissociation during acute hepatitis E infection. Debes JD; Groothuismink ZMA; Doukas M; de Man RA; Boonstra A Int J Infect Dis; 2019 Oct; 87():39-42. PubMed ID: 31408707 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy. Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933 [TBL] [Abstract][Full Text] [Related]
28. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus. Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835 [TBL] [Abstract][Full Text] [Related]
29. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein. Schofield DJ; Glamann J; Emerson SU; Purcell RH J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861 [TBL] [Abstract][Full Text] [Related]
30. Design and production of a multiepitope construct derived from hepatitis E virus capsid protein. Taherkhani R; Farshadpour F; Makvandi M J Med Virol; 2015 Jul; 87(7):1225-34. PubMed ID: 25784455 [TBL] [Abstract][Full Text] [Related]
31. Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4. Wang Y; Zhang H; Li Z; Gu W; Lan H; Hao W; Ling R; Li H; Harrison TJ J Clin Microbiol; 2001 Dec; 39(12):4370-9. PubMed ID: 11724847 [TBL] [Abstract][Full Text] [Related]
32. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319 [TBL] [Abstract][Full Text] [Related]
33. Application of serologic assays for diagnosing acute hepatitis E in national surveillance of a nonendemic area. Wu WC; Su CW; Yang JY; Lin SF; Chen JY; Wu JC J Med Virol; 2014 Apr; 86(4):720-8. PubMed ID: 24395716 [TBL] [Abstract][Full Text] [Related]
35. Role of TLR gene expression and cytokine profiling in the immunopathogenesis of viral hepatitis E. Majumdar M; Ratho RK; Chawla Y; Singh MP J Clin Virol; 2015 Dec; 73():8-13. PubMed ID: 26512422 [TBL] [Abstract][Full Text] [Related]
36. [Dynamics of anti-HEV ORF2, ORF3, IgM and IgG in serial sera of patients with hepatitis E and their clinical significance]. Ruan B; Zhuang H; Ma Y Zhonghua Yi Xue Za Zhi; 1998 Jul; 78(7):498-500. PubMed ID: 10923456 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. Jilani N; Das BC; Husain SA; Baweja UK; Chattopadhya D; Gupta RK; Sardana S; Kar P J Gastroenterol Hepatol; 2007 May; 22(5):676-82. PubMed ID: 17444855 [TBL] [Abstract][Full Text] [Related]
38. Study of cellular immune response against Hepatitis E virus (HEV). Prabhu SB; Gupta P; Durgapal H; Rath S; Gupta SD; Acharya SK; Panda SK J Viral Hepat; 2011 Aug; 18(8):587-94. PubMed ID: 20579277 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis E virus: neutralizing sites, diagnosis, and protective immunity. Zhang J; Li SW; Wu T; Zhao Q; Ng MH; Xia NS Rev Med Virol; 2012 Sep; 22(5):339-49. PubMed ID: 22645002 [TBL] [Abstract][Full Text] [Related]
40. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients. Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]